DEXA Interpretation and Management for Late 70s Patient
Interpretation: Low Bone Mass (Osteopenia) at Femoral Neck
This patient has osteopenia (low bone mass) based on the femoral neck T-score of -1.2, while the lumbar spine and total hip show normal bone density. 1
Key DEXA Findings:
- Lumbar spine (L1-L4): Normal BMD with T-score of -0.2 (≥ -1.0 indicates normal) 1
- Left femoral neck: Osteopenia with T-score of -1.2 (between -1.0 and -2.5 defines osteopenia) 1
- Left total hip: Normal BMD with T-score of -0.5 1
- Trabecular Bone Score: 1.416 (suggests good bone microarchitecture)
- Z-scores: All positive, indicating BMD is above average for age 1
The diagnostic classification is based on the lowest T-score at any recommended site, which in this case is the femoral neck at -1.2. 1
Treatment Decision Algorithm
Step 1: Assess for Prior Fragility Fractures
- If prior low-trauma fracture exists (hip, spine, forearm, humerus, pelvis, ribs, tibia): This automatically establishes osteoporosis diagnosis and warrants immediate pharmacologic treatment, regardless of T-score 1
- If no prior fracture: Proceed to Step 2
Step 2: Calculate 10-Year Fracture Risk Using FRAX
You must calculate FRAX score using the patient's:
- Age (late 70s)
- Sex
- BMI
- Prior fracture history
- Parental hip fracture history
- Current smoking status
- Glucocorticoid use
- Rheumatoid arthritis
- Secondary osteoporosis causes
- Alcohol consumption
- Femoral neck BMD 1, 2
Step 3: Treatment Thresholds
Pharmacologic treatment is warranted if: 2
- 10-year hip fracture probability > 5%, OR
- 10-year major osteoporotic fracture probability > 20%
For patients in their late 70s with osteopenia, FRAX scores frequently exceed these thresholds due to age alone, making treatment likely indicated. 3
Non-Pharmacologic Management (Universal for All Patients)
All patients with osteopenia should receive: 1
- Calcium supplementation: 1000-1200 mg daily 4
- Vitamin D supplementation: 800-1000 IU daily 1, 4
- Weight-bearing exercise: Regular physical activity 1
- Fall prevention strategies: Home safety assessment, balance training
- Smoking cessation if applicable
- Limit alcohol consumption to ≤2 drinks per day
Pharmacologic Treatment Options (If FRAX Thresholds Met)
First-Line: Oral Bisphosphonates 5
- Alendronate 70 mg once weekly, OR 6
- Risedronate 35 mg once weekly
- Must be taken on empty stomach with full glass of water, remain upright for 30 minutes 6
Alternative Options (If Bisphosphonates Contraindicated/Not Tolerated): 5
- Denosumab 60 mg subcutaneously every 6 months 7, 4
- Critical warning: If denosumab is ever discontinued, MUST transition to bisphosphonate to prevent rebound bone loss and multiple vertebral fractures 7
- Selective estrogen receptor modulators (SERMs) in younger postmenopausal women 3
Monitoring Strategy
Follow-up DEXA Scanning: 4
- Repeat DEXA in 1-2 years on the same machine using the same protocol 1
- Compare absolute BMD values (g/cm²), NOT T-scores or Z-scores 1
- Changes must exceed the Least Significant Change (LSC) to be considered clinically meaningful 1
- Maximum acceptable LSC: 5.0% for total hip, 5.3% for lumbar spine 1
Vertebral Fracture Assessment (VFA):
Consider VFA imaging at baseline, especially given patient's age (late 70s), as: 1
- 38% of patients ≥65 years with vertebral fractures have osteoporosis by BMD criteria, but many have osteopenia or normal BMD 1
- Vertebral fractures are the strongest predictor of future fractures and automatically warrant treatment 4
Critical Pitfalls to Avoid
Do not ignore osteopenia in elderly patients: The majority of osteoporotic fractures occur in individuals with osteopenic T-scores, not osteoporosis 3
Do not treat based on T-score alone in osteopenia: Treatment requires either prior fracture OR high FRAX score 3
Do not use Z-scores for treatment decisions in adults: Z-scores are for identifying secondary causes; T-scores determine treatment 1
Do not assume lumbar spine is most important: In elderly patients, hip BMD (especially femoral neck) is the best predictor of hip fracture risk 2
Do not forget to screen for secondary causes of osteoporosis: Given the patient's age, evaluate for vitamin D deficiency, hyperparathyroidism, hyperthyroidism, celiac disease, multiple myeloma, and medication effects (especially glucocorticoids) 5, 2
Secondary Osteoporosis Screening
Order baseline laboratory tests: 5, 2
- Complete blood count
- Serum calcium, phosphate, alkaline phosphatase
- 25-hydroxyvitamin D level
- Thyroid-stimulating hormone
- Serum protein electrophoresis (if clinically indicated)
- Testosterone level (in men)